FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2069778931> ?p ?o ?g. }

• W2069778931 endingPage "60.e1" @default.
• W2069778931 startingPage "47" @default.
• W2069778931 abstract "Although combination pharmacotherapy is common in child and adolescent psychiatry, there has been little research evaluating it. The value of adding risperidone to concurrent psychostimulant and parent training (PT) in behavior management for children with severe aggression was tested.One hundred sixty-eight children 6 to 12 years old (mean age 8.89 ± 2.01 years) with severe physical aggression were randomized to a 9-week trial of PT, stimulant (STIM), and placebo (Basic treatment; n = 84) or PT, STIM, and risperidone (Augmented treatment; n = 84). All had diagnoses of attention-deficit/hyperactivity disorder and oppositional-defiant disorder (n = 124) or conduct disorder (n = 44). Children received psychostimulant (usually Osmotic Release Oral System methylphenidate) for 3 weeks, titrated for optimal effect, while parents received PT. If there was room for improvement at the end of week 3, placebo or risperidone was added. Assessments included parent ratings on the Nisonger Child Behavior Rating Form (Disruptive-Total subscale was the primary outcome) and Antisocial Behavior Scale; blinded clinicians rated change on the Clinical Global Impressions scale.Compared with Basic treatment (PT + STIM [44.8 ± 14.6 mg/day] + placebo [1.88 mg/day ± 0.72]), Augmented treatment (PT + STIM [46.1 ± 16.8 mg/day] + risperidone [1.65 mg/day ± 0.75]) showed statistically significant improvement on the Nisonger Child Behavior Rating Form Disruptive-Total subscale (treatment-by-time interaction, p = .0016), the Nisonger Child Behavior Rating Form Social Competence subscale (p = .0049), and Antisocial Behavior Scale Reactive Aggression subscale (p = .01). Clinical Global Impressions scores were substantially improved for the 2 groups but did not discriminate between treatments (Clinical Global Impressions-Improvement score ≤2, 70% for Basic treatment versus 79% for Augmented treatment). Prolactin elevations and gastrointestinal upset occurred more with Augmented treatment; other adverse events differed modestly from Basic treatment; weight gain in the Augmented treatment group was minor.Risperidone provided moderate but variable improvement in aggressive and other seriously disruptive child behaviors when added to PT and optimized stimulant treatment. Clinical trial registration information-Treatment of Severe Childhood Aggression (The TOSCA Study), URL: http://clinicaltrials.gov, unique identifier: NCT00796302." @default.
• W2069778931 created "2016-06-24" @default.
• W2069778931 creator A5000585575 @default.
• W2069778931 creator A5003135433 @default.
• W2069778931 creator A5009585057 @default.
• W2069778931 creator A5011948151 @default.
• W2069778931 creator A5015388521 @default.
• W2069778931 creator A5032518803 @default.
• W2069778931 creator A5035236451 @default.
• W2069778931 creator A5037364414 @default.
• W2069778931 creator A5038086394 @default.
• W2069778931 creator A5041630323 @default.
• W2069778931 creator A5042787535 @default.
• W2069778931 creator A5042947456 @default.
• W2069778931 creator A5046341093 @default.
• W2069778931 creator A5048500503 @default.
• W2069778931 creator A5057846005 @default.
• W2069778931 creator A5064909248 @default.
• W2069778931 creator A5069598980 @default.
• W2069778931 creator A5078168361 @default.
• W2069778931 creator A5083864774 @default.
• W2069778931 creator A5087975138 @default.
• W2069778931 creator A5087993762 @default.
• W2069778931 creator A5088965802 @default.
• W2069778931 date "2014-01-01" @default.
• W2069778931 modified "2023-10-17" @default.
• W2069778931 title "What Does Risperidone Add to Parent Training and Stimulant for Severe Aggression in Child Attention-Deficit/Hyperactivity Disorder?" @default.
• W2069778931 cites W1964957356 @default.
• W2069778931 cites W1974988334 @default.
• W2069778931 cites W1975538955 @default.
• W2069778931 cites W1981072297 @default.
• W2069778931 cites W1983302342 @default.
• W2069778931 cites W1984246160 @default.
• W2069778931 cites W1987240387 @default.
• W2069778931 cites W1999689270 @default.
• W2069778931 cites W2013051231 @default.
• W2069778931 cites W2014360912 @default.
• W2069778931 cites W2020085742 @default.
• W2069778931 cites W2021155799 @default.
• W2069778931 cites W2031582693 @default.
• W2069778931 cites W2059414971 @default.
• W2069778931 cites W2063648119 @default.
• W2069778931 cites W2071199156 @default.
• W2069778931 cites W2076287319 @default.
• W2069778931 cites W2093129906 @default.
• W2069778931 cites W2095775564 @default.
• W2069778931 cites W2102729471 @default.
• W2069778931 cites W2106249983 @default.
• W2069778931 cites W2107486873 @default.
• W2069778931 cites W2133752375 @default.
• W2069778931 cites W2139910250 @default.
• W2069778931 cites W2141344740 @default.
• W2069778931 cites W2165379748 @default.
• W2069778931 cites W2167767364 @default.
• W2069778931 cites W4238677474 @default.
• W2069778931 cites W4248821689 @default.
• W2069778931 cites W4942257 @default.
• W2069778931 doi "https://doi.org/10.1016/j.jaac.2013.09.022" @default.
• W2069778931 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3984501" @default.
• W2069778931 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24342385" @default.
• W2069778931 hasPublicationYear "2014" @default.
• W2069778931 type Work @default.
• W2069778931 sameAs 2069778931 @default.
• W2069778931 citedByCount "113" @default.
• W2069778931 countsByYear W20697789312014 @default.
• W2069778931 countsByYear W20697789312015 @default.
• W2069778931 countsByYear W20697789312016 @default.
• W2069778931 countsByYear W20697789312017 @default.
• W2069778931 countsByYear W20697789312018 @default.
• W2069778931 countsByYear W20697789312019 @default.
• W2069778931 countsByYear W20697789312020 @default.
• W2069778931 countsByYear W20697789312021 @default.
• W2069778931 countsByYear W20697789312022 @default.
• W2069778931 countsByYear W20697789312023 @default.
• W2069778931 crossrefType "journal-article" @default.
• W2069778931 hasAuthorship W2069778931A5000585575 @default.
• W2069778931 hasAuthorship W2069778931A5003135433 @default.
• W2069778931 hasAuthorship W2069778931A5009585057 @default.
• W2069778931 hasAuthorship W2069778931A5011948151 @default.
• W2069778931 hasAuthorship W2069778931A5015388521 @default.
• W2069778931 hasAuthorship W2069778931A5032518803 @default.
• W2069778931 hasAuthorship W2069778931A5035236451 @default.
• W2069778931 hasAuthorship W2069778931A5037364414 @default.
• W2069778931 hasAuthorship W2069778931A5038086394 @default.
• W2069778931 hasAuthorship W2069778931A5041630323 @default.
• W2069778931 hasAuthorship W2069778931A5042787535 @default.
• W2069778931 hasAuthorship W2069778931A5042947456 @default.
• W2069778931 hasAuthorship W2069778931A5046341093 @default.
• W2069778931 hasAuthorship W2069778931A5048500503 @default.
• W2069778931 hasAuthorship W2069778931A5057846005 @default.
• W2069778931 hasAuthorship W2069778931A5064909248 @default.
• W2069778931 hasAuthorship W2069778931A5069598980 @default.
• W2069778931 hasAuthorship W2069778931A5078168361 @default.
• W2069778931 hasAuthorship W2069778931A5083864774 @default.
• W2069778931 hasAuthorship W2069778931A5087975138 @default.
• W2069778931 hasAuthorship W2069778931A5087993762 @default.
• W2069778931 hasAuthorship W2069778931A5088965802 @default.
• W2069778931 hasBestOaLocation W20697789311 @default.

• next